Immunotherapy (Camrelizumab): clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Immunotherapy (Camrelizumab)

• Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer
  NCT05202314 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Immunotherapy (Camrelizumab)?

1 recruiting trial across 5 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.